User profiles for Eero Poukka
 | Eero PoukkaFinnish Institute for Health and Welfare Verified email at thl.fi Cited by 220 |
[HTML][HTML] Cohort study of Covid-19 vaccine effectiveness among healthcare workers in Finland, December 2020-October 2021
E Poukka, U Baum, AA Palmu, TO Lehtonen, H Salo… - Vaccine, 2022 - Elsevier
Recently, Covid-19 vaccine effectiveness has decreased especially against mild disease
due to emergence of the Delta variant and waning protection. In this register-based study …
due to emergence of the Delta variant and waning protection. In this register-based study …
[HTML][HTML] High vaccine effectiveness against severe COVID-19 in the elderly in Finland before and after the emergence of Omicron
U Baum, E Poukka, T Leino, T Kilpi, H Nohynek… - BMC Infectious …, 2022 - Springer
Background The elderly are highly vulnerable to severe COVID-19. Waning immunity and
emergence of Omicron have caused concerns about reduced effectiveness of COVID-19 …
emergence of Omicron have caused concerns about reduced effectiveness of COVID-19 …
Comparative effectiveness of bivalent BA. 4-5 and BA. 1 mRNA booster vaccines among adults aged≥ 50 years in Nordic countries: nationwide cohort study
Objective To estimate the effectiveness of the bivalent mRNA booster vaccines containing
the original SARS-CoV-2 and omicron BA.4-5 or BA.1 subvariants as the fourth dose against …
the original SARS-CoV-2 and omicron BA.4-5 or BA.1 subvariants as the fourth dose against …
Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based …
Objective To investigate the comparative vaccine effectiveness of heterologous booster
schedules (ie, three vaccine doses) compared with primary schedules (two vaccine doses) and …
schedules (ie, three vaccine doses) compared with primary schedules (two vaccine doses) and …
Effectiveness of immunization products against medically attended respiratory syncytial virus infection: generic protocol for a test-negative case-control study
C van Roekel, E Poukka, T Turunen… - The Journal of …, 2024 - academic.oup.com
Monitoring the real-life effectiveness of respiratory syncytial virus (RSV) products is of major
public health importance. This generic protocol for a test-negative design study aims to …
public health importance. This generic protocol for a test-negative design study aims to …
[HTML][HTML] Effectiveness of vaccination against SARS-CoV-2 infection and Covid-19 hospitalisation among Finnish elderly and chronically ill—An interim analysis of a …
U Baum, E Poukka, AA Palmu, H Salo, TO Lehtonen… - PLoS …, 2021 - journals.plos.org
Background In Finland, both mRNA and adenovirus vector (AdV) Covid-19 vaccines have
been used after the vaccination campaign started on December 27, 2020. Vaccination of the …
been used after the vaccination campaign started on December 27, 2020. Vaccination of the …
Bivalent booster effectiveness against severe COVID-19 outcomes in Finland, September 2022–March 2023
E Poukka, H Nohynek, S Goebeler, T Leino, U Baum - medRxiv, 2023 - medrxiv.org
Bivalent COVID-19 vaccines were introduced in 2022 but knowledge of their effectiveness
against severe COVID-19 outcomes is currently limited. In Finnish register-based cohort …
against severe COVID-19 outcomes is currently limited. In Finnish register-based cohort …
Detection of SARS-CoV-2 infection in gargle, spit, and sputum specimens
The gold standard for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection diagnosis is reverse transcription (RT)-PCR from a nasopharyngeal swab specimen (…
infection diagnosis is reverse transcription (RT)-PCR from a nasopharyngeal swab specimen (…
Effectiveness of vaccines and monoclonal antibodies against respiratory syncytial virus: Generic protocol for register-based cohort study
E Poukka, C van Roekel, T Turunen… - The Journal of …, 2024 - academic.oup.com
Several immunization products are currently being developed against respiratory syncytial
virus (RSV) for children, pregnant females, and older adults, and some products have already …
virus (RSV) for children, pregnant females, and older adults, and some products have already …
[HTML][HTML] Initial assessment of the COVID-19 vaccination's impact on case numbers, hospitalisations and deaths in people aged 80 years and older, 15 EU/EEA …
…, J Beauté, V Učakar, MG Vitek, E Poukka… - …, 2021 - eurosurveillance.org
Prioritisation of elderly people in COVID-19 vaccination campaigns aimed at reducing severe
outcomes in this group. Using EU/EEA surveillance and vaccination uptake, we estimated …
outcomes in this group. Using EU/EEA surveillance and vaccination uptake, we estimated …